Ullet index:Eisai Co.,Ltd.:4523

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Eisai Co.,Ltd. Go to web site 4523 Medicals 東証プライム March 1, 2000 1961.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

Eisai Co.,Ltd. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 799,959
plusup
748,822
plusup
701,601
plusup
678,127
plusup
628,119
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp 55,432
plusup
47,954
plusup
41,942
plusdown
121,767
plusup
63,385
plus
Operating Cash Flow(OFC)Help -1,772
plusdown
117,589
plusup
73,067
plusdown
102,782
plusdown
103,714
plus
Free Cash Flow(FCF)Help -24,495
plusdown
88,741
plusup
36,981
plusdown
75,157
plusdown
95,796
plus
OFC - Net IncomeHelp 76
plusdown
78
plusup
75
plusdown
76
plusup
71
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -0.73%
plusdown
47.99%
plusup
40.27%
plusdown
53.44%
plusup
49.82%
plus
Current Assets / Amount of SalesHelp 32.74%
plusup
32.40%
plusup
28.09%
plusup
27.65%
plusdown
32.38%
plus
Free Cash Revenue RatioHelp -3.29%
plusdown
11.73%
plusup
5.73%
plusdown
10.80%
plusdown
14.90%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Eisai Co.,Ltd.

Company where related level is highHelp

Mitsubishi Tanabe Pharma Corporation
Sanko Junyaku Co.,Ltd.
Shionogi & Co.,Ltd.
Tsubota Laboratory Incorporated
SEIKAGAKU CORPORATION
Mochida Pharmaceutical Co.,Ltd.
Daito Pharmaceutical Co.,Ltd.
Cyfuse Biomedical K.K.
Modalis Therapeutics Corporation
PeptiDream Inc.